Recombinant Human RGS2 Protein，His

RGS2 (Regulator of G protein signaling 2) is a critical member of the RGS family that plays a vital role in modulating G protein-coupled receptor (GPCR) signaling pathways. These pathways are essential for numerous physiological processes, including hormone signaling, neurotransmission, and immune responses. Dysregulation of RGS2 has been implicated in various pathological conditions such as hypertension, anxiety disorders, and heart failure, highlighting its potential as a therapeutic target. Research on RGS2 often involves the production of recombinant RGS2 protein, which allows scientists to study its structure, function, and interactions in controlled experimental settings. Recombinant RGS2 can be expressed in various systems, such as bacteria or mammalian cells, providing insights into its biochemical properties and role in cellular signaling. Understanding the molecular mechanisms by which RGS2 modulates G protein signaling is crucial, as it may lead to the development of novel pharmacological agents that can selectively modulate these pathways, offering new therapeutic approaches for diseases associated with RGS2 dysregulation. Additionally, studies on RGS2 reconstitution in cellular models can illuminate its potential roles in drug efficacy and safety, thus broadening the scope of cardiovascular and psychiatric treatments. Overall, the research surrounding RGS2 recombinant protein is a promising field that may yield significant advancements in understanding and treating various diseases linked to GPCR signaling.